David Evans

Risk & Reward Activist David Evans weighs in on next steps in cure advocacy & research by Jeannie Wraight In the late 1980s and throughout the ’90s,...

IV Drug Users & HIV Vaccine Response

Everyone Counts Differences in intravenous drug users may affect their response to an HIV vaccine by Jeannie Wraight Prevention strategies such as Treatment as Prevention, PrEP, syringe...

Cure Research Setback?

Shock and Kill Research unveils new info about latent HIV reservoirs, signaling a possible cure setback by Jeannie Wraight Amid several recent successes in the pursuit for...

ABX 464 Aims to Reduce HIV Reservoirs

Revving Up Investigational agent ABX 464 seeks to reduce HIV reservoirs by Jeannie Wraight ABX 464 is making its way through clinical trials, showing strong potential as...

Novel Cure Research Supported by amfAR

Deciphering the Puzzle A new round of amfAR's Countdown to a Cure initiative grants support novel cure research by Jeannie Wraight amfAR has awarded a new round...

The New Administration & the Threat to HIV Care and Cure...

Buyer Beware The new administration may threaten HIV care and cure research by Jeannie Wraight Our way of life in the U.S. has already drastically changed as...

Why We Need a Vaccine

As with any viral outbreak, the two main goals from Day One of the known HIV epidemic/pandemic have been controlling the spread of the...

LATEST POSTS

Bruce Ward: March 2008

Time Differences Playwright Bruce Ward talks with A&U’s Chael Needle about his new play, Lazarus Syndrome, finding support & the need to stay on top...

Edmund White Honored by PEN

Becoming Self-Aware

Edmund White: February 2008